Rapid eradication of colon carcinoma by Clostridium perfringens Enterotoxin suicidal gene therapy
Pahle, Jessica ;  Menzel, Lutz ;  Niesler, Nicole ;  Kobelt, Dennis ;  Aumann, Jutta ;  Rivera, Maria ;  Walther, Wolfgang

HaupttitelRapid eradication of colon carcinoma by Clostridium perfringens Enterotoxin suicidal gene therapy
AutorPahle, Jessica
AutorMenzel, Lutz
AutorNiesler, Nicole
AutorKobelt, Dennis
AutorAumann, Jutta
AutorRivera, Maria
AutorWalther, Wolfgang
Seitenzahl14 S.
Freie SchlagwörterClostridium perfringens enterotoxin (CPE); Colon cancer; Gene therapy; Suicide gene
DDC610 Medizin und Gesundheit
Auch erschienen inBMC Cancer. - 17 (2017), Artikel Nr. 129

Bacterial toxins have evolved to an effective therapeutic option for cancer therapy. The Clostridium perfringens enterotoxin (CPE) is a pore-forming toxin with selective cytotoxicity. The transmembrane tight junction proteins claudin-3 and -4 are known high affinity CPE receptors. Their expression is highly upregulated in human cancers, including breast, ovarian and colon carcinoma. CPE binding to claudins triggers membrane pore complex formation, which leads to rapid cell death. Previous studies demonstrated the anti-tumoral effect of treatment with recombinant CPE-protein. Our approach aimed at evaluation of a selective and targeted cancer gene therapy of claudin-3- and/or claudin-4- expressing colon carcinoma in vitro and in vivo by using translation optimized CPE expressing vector.


In this study the recombinant CPE and a translation optimized CPE expressing vector (optCPE) was used for targeted gene therapy of claudin-3 and/or -4 overexpressing colon cancer cell lines. All experiments were performed in the human SW480, SW620, HCT116, CaCo-2 and HT-29 colon cancer and the isogenic Sk-Mel5 and Sk-Mel5 Cldn-3-YFP melanoma cell lines. Claudin expression analysis was done at protein and mRNA level, which was confirmed by immunohistochemistry. The CPE induced cytotoxicity was analyzed by the MTT cytotoxicity assay. In addition patient derived colon carcinoma xenografts (PDX) were characterized and used for the intratumoral in vivo gene transfer of the optCPE expressing vector in PDX bearing nude mice.


Claudin-3 and -4 overexpressing colon carcinoma lines showed high sensitivity towards both recCPE application and optCPE gene transfer. The positive correlation between CPE cytotoxicity and level of claudin expression was demonstrated. Transfection of optCPE led to targeted, rapid cytotoxic effects such as membrane disruption and necrosis in claudin overexpressing cells. The intratumoral optCPE in vivo gene transfer led to tumor growth inhibition in colon carcinoma PDX bearing mice in association with massive necrosis due to the intratumoral optCPE expression.


This novel approach demonstrates that optCPE gene transfer represents a promising and efficient therapeutic option for a targeted suicide gene therapy of claudin-3 and/or claudin-4 overexpressing colon carcinomas, leading to rapid and effective tumor cell killing in vitro and in vivo.
PDF-Datei von FUDOCS_document_000000026845
Falls Ihr Browser eine Datei nicht öffnen kann, die Datei zuerst herunterladen und dann öffnen.
Fachbereich/EinrichtungMedizinische Fakultät Charité - Universitätsmedizin Berlin
Dokumententyp/-SammlungenWissenschaftlicher Artikel
RechteCreative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Anmerkungen des AutorsDer Artikel wurde in einer reinen Open-Access-Zeitschrift publiziert.
Erstellt am21.04.2017 - 10:11:02
Letzte Änderung21.04.2017 - 10:20:32
Statische URLhttp://edocs.fu-berlin.de/docs/receive/FUDOCS_document_000000026845